Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • FAQs

    Global Therapeutic Respiratory Devices Market size was valued at USD 18.92 Billion in 2024 and is poised to grow from USD 20.11 Billion in 2025 to USD 32.79 Billion by 2033, growing at a CAGR of 6.3% during the forecast period (2026–2033). 

    The market is fragmented with presence of key players who employ various growth strategies including mergers and acquisitions, collaborations, product releases, and partnership with local players to maintain dominance. Some of the key players include BD, General Electric Company, Chart Industries, Koninklijke Philips N.V, Compumedics Limited, ICU Medical, Inc. and Invacare Corporation. Innovation and development of new products is the key strategies of these major players to increase the consumer base. 'ResMed Inc. (United States) ', 'Medtronic plc (Ireland) ', 'Koninklijke Philips N.V. (Netherlands) ', 'Fisher & Paykel Healthcare Limited (New Zealand) ', 'GE Healthcare (United States) ', 'Dragerwerk AG & Co. KGaA (Germany) ', 'Teleflex Incorporated (United States) ', 'Hamilton Medical AG (Switzerland) ', 'Invacare Corporation (United States) ', 'CAIRE Inc. (United States) ', 'Nihon Kohden Corporation (Japan) ', 'Inogen Inc. (United States) ', 'Masimo Corporation (United States) ', 'Chart Industries (United States) ', 'Compumedics Limited (Australia) ', 'VitalAire (France) ', 'Vivisol (Italy) ', 'React Health (United States) '

    The demand for therapeutic respiratory devices is driven by the increase in respiratory conditions such asthma and chronic obstructive pulmonary disease.

    In the therapeutic respiratory device market, intelligent ventilators, portable PAP machines, smart inhalers, and nebulizers are all growing in popularity and assisting in giving clinicians real-time monitoring and data transfer. The market for therapeutic respiratory devices is anticipated to grow quickly during the forecast period due to the high prevalence of respiratory illnesses in India, Brazil, China, and Japan.

    North America dominated the global market in 2021.This can be attributed to a sizable elderly population as well as the increased prevalence of chronic respiratory illnesses. Additionally, the major share of the North American market is due to the availability of reimbursement in the U.S. healthcare centres accounts, growing public awareness of healthcare issues, improved healthcare infrastructure, an increase in the number of outpatient surgeries, and economic growth that is aided by expanding insurance coverage. According to the United States Death Statistics, in 2021 respiratory disorders claimed the lives of 44,630 people. The market for therapeutic respiratory devices is also anticipated to grow in the next years as a result of rising healthcare costs and an increase in respiratory illnesses in the United States.

    Feedback From Our Clients

    Global Therapeutic Respiratory Devices Market

    Report ID: SQMIG35A2647

    $5,300
    BUY NOW